> Workshop programme
Geneva, this four-day WTO Workshop on the TRIPS Agreement and Public Health
was part of the WTO technical cooperation and capacity-building activities —
“TRIPS” is “trade-related intellectual property rights”, the name used for
the WTO’s intellectual property agreement.
Like earlier workshops held in Geneva since 2005, this capacity-building
activity aimed to ensure that the participants have the information
necessary so that their countries can make use of the TRIPS Agreement’s
flexibilities for public health purposes.
Among other subjects, the workshop looked at the additional flexibility
agreed by members in August 2003 and
to allow generic versions of patented medicines to be made under compulsory
licence for export to countries that cannot manufacture the medicines
themselves, sometimes called the “paragraph 6 system”.
TRIPS public health flexibilities figure prominently in other WTO national
and regional technical cooperation events. Similar regional workshops have
also been held for African countries in Mauritius in June 2006, for the Asia
Pacific region in Macao in July 2007 and for Latin American and Caribbean
countries in 2008.
The scene for the workshop was set by an introductory session on the
interface between intellectual property rights and public health, which was
jointly given by the WTO, the World Health Organization (WHO) and the World
Intellectual Property Organization (WIPO). Subsequent presentations by WTO
officials provided an introduction to the key elements of the TRIPS
Agreement and related WTO instruments, in particular the provisions of
direct relevance to public health, the Doha Declaration on the TRIPS
Agreement and Public Health, and the paragraph 6 system. To complete the
picture, representatives from some WTO member governments discussed TRIPS
flexibilities and reported on the implementing legislation in place allowing
for exports and imports under the paragraph 6 system. Practical exercises
enabled participants to apply the acquired knowledge to concrete cases.
With a view to putting the issue of TRIPS and public health in the context
of a wider action to address problems related to public health, a number of
other speakers shared their experiences and views regarding certain key
issues of direct relevance to public health. Among the issues covered were,
in particular, the management of intellectual property rights as applied to
concrete health-related projects, questions related to the regulatory
approval, quality control and effectiveness of medicines, as well as to
competition and procurement. The list of invited speakers included
representatives of the research and development (R&D) and generic
industries, Médecins sans Frontières (Doctors without Frontiers), the Global
Fund, the Medicines for Malaria Venture and the African Network for Drugs
and Diagnostics Innovation.
The participants came from: Armenia, Cambodia, Cuba, Grenada, Hong Kong
China, Indonesia, Iraq, Jordan, Korea, Laos, Lebanon, Mexico, Moldova,
Nigeria, Oman, Peru, Philippines, Russia, Samoa, Senegal, Sierra Leone,
Sudan, Chinese Taipei and Ukraine.
RSS news feeds
> Problems viewing this page?
Please contact firstname.lastname@example.org giving details of the operating system and web browser you are using.